semaglutide is it safe Compounded Safety: What You Should Know Dangers of Taking Ozempic for

N Engl J Med 389:22212232

Better Value: Affordable pricing that matches the quality of care

Meet our doctors Last reviewed: 19 Jun 2026 Sources Effectiveness of Dulaglutide in the Real World and in Special Populations of Type 2 Diabetic Patients (2020) NIH [accessed 27 January 2026] Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial (2023) The Lancet [accessed 27 January 2026] How to use Mounjaro (2023) Mounjaro [accessed 27 January 2026] Lillys SURMONT-2 results published in The Lancet show tirzepatide achieve a mean weight reduction of 15.7% at the highest dose (15mg) in adults with obesity or overweight and type 2 diabetes (2023) Lillys INVESTORS [accessed 27 January 2026] MHRA authorised diabetes drug Mounjaro (tirzepatide) for weight management and weight loss (2023) GOV.UK

Whether you are a good candidate for a GLP-1 (Glucagon-like peptide 1) weight-loss program depends on your health profile, medical history, lifestyle, body mass index (BMI), and other factors

If you want to quit semaglutide, talk to your healthcare provider first